Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLpa Regulatory News (LPA)

Share Price Information for Lpa (LPA)

Share Price is delayed by 15 minutes
Get Live Data
63.50    0.00 (0.00%)
Bid:
62.00
Ask:
65.00
Spread: 3.00 (4.839%)
Market Cap: £8.39m
LPA Live PriceLast checked at - London Stock Exchange

Intraday Lpa Share Chart

Tender Offer

1 Nov 2006 07:00

LPA Group PLC01 November 2006 LPA Group Plc (the "Company")1 November 2006 The following has been extracted from a letter sent to shareholders yesterdayevening. "Unsolicited Tender Offer SHAREHOLDERS ADVISED TO TAKE NO ACTION On Thursday, 26 October, your Board received notice of a tender offer fromAndrew Perloff for up to 3,095,968 shares, representing 28.39% of our issuedshare capital, at 25p per share. Your Board has had no direct contact with Mr Perloff or anyone connected withhim. We are concerned that he is seeking to gain effective control of yourcompany without launching a full offer for the company. Shareholders should note that the tender offer document, issued by his adviser,John East & Partners, on behalf of Mr Perloff, includes no mention whatsoever ofthe reasons behind this tender offer. Shareholders should be aware that in the interim statement published on 22 June2006, the unaudited balance sheet as at 31 March 2006 showed equityshareholders' funds of £6.02 million, equating to 55.2p per share. This figure does not take into account any uplift through the revaluation of ourfreehold property assets. Our 1.5 acre headquarters site at Saffron Walden, forexample, is located in an area zoned for residential development and is believedby the Board to be worth substantially more than its current book value. As announced in our formal response today to the tender offer, your Board willnot be accepting in respect of its shareholdings, which total 1,169,540 shares(10.73% of the issued share capital). The Group's financial year closed on 30 September and your Board will be writingto you again shortly to update you on current trading, and to give you moredetails of our forward order book. In the meantime, I strongly urge shareholders to follow our lead and to ignorethis opportunistic tender offer." Enquiries: Peter Pollock Chief Executive 01799 512844Stephen Brett Finance Director 01799 512860James Glancy Teather & Greenwood Limited 020 7426 9000Robert Naylor Teather & Greenwood Limited 020 7426 9000 Gareth David College Hill 020 7457 2020 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Sep 20237:00 amRNSParticipation at upcoming trade conferences
26th Jul 202310:34 amRNSPerformance Share Plan
26th Jun 20237:00 amRNSConfirmation of Product Line Acquisition
22nd Jun 20237:00 amRNSUnaudited Interim Results
25th May 20237:00 amRNSContract Win and Orderbook
4th Apr 20239:40 amRNSHolding(s) in Company
29th Mar 20234:14 pmRNSDirector/PDMR Shareholding
28th Mar 20232:51 pmRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSProduct Line Acquisition
24th Mar 202310:39 amRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Statement
15th Feb 20237:00 amRNSContract Win and Orderbook
3rd Feb 20237:00 amRNSFinal Results
22nd Dec 20227:00 amRNSDirectorate Change
30th Nov 202211:32 amRNSDirector/PDMR Shareholding
28th Nov 20221:29 pmRNSHolding(s) in Company
25th Nov 20227:00 amRNSTrading Update
22nd Nov 202211:02 amRNSHolding(s) in Company
13th Sep 202210:33 amRNSHolding(s) in Company
9th Aug 202210:01 amRNSHolding(s) in Company
5th Aug 202210:03 amRNSHolding(s) in Company
2nd Aug 20224:56 pmRNSHolding(s) in Company
26th Jul 202211:30 amRNSLand Sale
6th Jul 20223:50 pmRNSHolding(s) in Company
28th Jun 20227:00 amRNSHalf-year Report
7th Jun 20221:45 pmRNSDirectorate Change
12th Apr 20229:43 amRNSHolding(s) in Company
24th Mar 20224:48 pmRNSResult of AGM
23rd Mar 20222:14 pmRNSHolding(s) in Company
23rd Feb 20227:00 amRNSChange of Adviser
8th Feb 20229:30 amRNSDirector/PDMR Shareholding
1st Feb 20227:00 amRNSExercise of Options & PDMR Dealings
31st Jan 202211:55 amRNSDirector/PDMR Shareholding
28th Jan 20222:59 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSFinal Results
12th Jan 20227:00 amRNSExercise of Options
30th Dec 20217:00 amRNSDirectorate Change
28th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 202111:53 amRNSYear End Trading Update
22nd Jul 202112:53 pmRNSBoard Changes
6th Jul 202111:52 amRNSHolding(s) in Company
5th Jul 20214:05 pmRNSHolding(s) in Company
1st Jul 20215:48 pmRNSDirector/PDMR Shareholding
1st Jul 20218:01 amRNSHolding(s) in Company
1st Jul 20218:01 amRNSHolding(s) in Company
24th Jun 20214:43 pmRNSExercise of Share Options & Director Shareholding
22nd Jun 20217:00 amRNSContract Award
17th Jun 20217:01 amRNSHalf-year Report
17th Jun 20217:00 amRNSAppointment of Non-Executive Director
13th May 20215:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.